Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 27, 2001 - Issue 5
Submit an article Journal homepage
67
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Acrylic Resins as Rate-Controlling Membranes in Novel Formulation of a Nine-Day 17β-Estradiol Transdermal Delivery System: In Vitro and Release Modifier Effect Evaluation

M. Rafiee-Tehrani College of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14395-459, Tehran, Iran
,
N. Safaii-Nikui College of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14395-459, Tehran, Iran
,
H. Peteriet
&
T. Beckert
Pages 431-437 | Published online: 30 Apr 2001

REFERENCES

  • Chien Y. W. Rate-Control Drug Delivery System: Controlled Release Versus Sustained Release. Med. Prog. Tech. 1989; 15: 21–46
  • Yu J. W., Chien T. Y., Chien Y. W. Transdermal Dual-Controlled Delivery of Testosterone and Estradiol: Impact of System Design. Drug Dev. Ind. Pharm. 1991; 17: 1883–1904
  • Chien Y. W. Novel Drug Delivery Systems. 2nd Ed., Marcel Dekker, Inc., New York 1992; 1–42
  • Steingold K. A., Laufer L., Chetkowski R. J., Defazio J. D., Matt D. W., Meldrum D. R., Judd H. L. Treatment of Hot Flashes with Transdermal Estradiol Administration. J. Clin. Endocrinol. Metab. 1985; 61: 627–632
  • Selby P. L., McGarrigle H. H.G., Peacock M. Comparison of the Effects of Oral and Transdermal Estradiol Administration on Oestrogen Metabolism, Protein Synthesis, Gonadotrophin Release, Bone Turnover and Climacteric Symptoms in Postmenopausal Women. Clin. Endocrinol. 1989; 30: 241–249
  • Ribot C., Tremollieres F., Pouilles J. M., Louvet J. P., Peyron R. Preventive Effects of Transdermal of 17β-Estradiol on Postmenopausal Bone Loss: A Two-Year Prospective Study. Obstet. Gynecol. 1990; 75: 425–465
  • Field C. S., Ory S. J., Wahner H. W., Herrmann R. R., Judd H. L., Riggs B. L. Preventive Effects of Transdermal 17β-Estradiol on Osteoporotic Changes After Surgical Menopause: A Two-Year Placebo-Controlled Trial. Am. J. Obstet. Gynecol. 1993; 168: 114–121
  • Kuhnz W., Gansau C., Mahler M. Pharmacokinetics of Estradiol, Free and Total Estrone, in Young Women Following Single Intravenous and Oral Administration of 17β-Estradiol. Arzneim Forsch 1993; 43: 966–973
  • Harrison L. I., Riedel D. J., Chang S. F., Jacobson J. P., Sellers J. A., Kanniainen C. M., Crowley J. K., Hinderling P. H. Comparative Serum Estradiol Profiles from a New Once-a-Week Transdermal Estradiol Patch and a Twice-a-Week Transdermal Estradiol Patch. Ther. Drug Monit. 1997; 19: 37–42
  • Rohr U. D., Ehrly A. M., Kuhl H. Plasma Profiles of Transdermal 17β-Estradiol Delivered by Two Different Matrix Patches. Arzneim Forsch 1997; 47: 761–768
  • U.S. Pharmacopeial Convention. United States Pharmacopoeia. 24th Rev., U.S. Pharmacopeial Convention, Rockville, MD 2000; 1947–1948
  • Shah V. P., Tymes N. W., Skelly J. P. Comparative In Vitro Release Profiles of Marketed Nitroglycerin Batches by Different Dissolution Methods. J. Controlled Release 1988; 7: 79–86
  • Loth H. Vehicular Influence on Transdermal Drug Penetration. Int. J. Pharm. 1991; 68: 1–10
  • Stantus G. C., Baker R. W. Transdermal Enhancer Patent Literature. J. Controlled Release 1993; 25: 1–20
  • Goldberg-Cettina M., Liu P., Nightingale J., Kurihora-Bergstrom T. Enhanced Transdermal Delivery of Estradiol In Vitro Using Binary Vehicles of Isopropyl Myristate and Short-Chain Alkanols. Int. J. Pharm. 1995; 114: 237–245
  • Rafiee-Tehrani M., Safaii-Nikui N., Toliat T., Petereit H., Beckert T. Acrylic Resins as Rate-Controlling Membranes in Delivery Unilaminate Device of Estradiol. 25th Int. Symp. Controlled Release Bioact. Mater. 1998; 28–29
  • Rafiee-Tehrani M., Safaii-Nikui N., Toliat T., Petereit H., Beckert T. Effect of plasticizers and enhancers on release behavior of estradiol from unilaminate TDD Patch. 26th Int. Symp. Control. Rel. Bioact. Mater. 1999; 455–456
  • Chien Y. W., Lambert H. J. Solubilization of Steroids by Multiple Co-Solvent Systems. Chem. Pharm. Bull. 1975; 23: 1085–1090
  • Lehmann K. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, J. W. McGinigy. Marcel Dekker, Inc., New York 1989; 153–245
  • Peppas K. A., Meadows D. L. Macromolecular Structure and Solute Diffusion in Membranes: An Overview of Recent Theories. J. Membrane Sci. 1982; 16: 361–377
  • Ghebre-Sellassie I. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, J. W. McGinity. Marcel Dekker, Inc., New York 1989; 247–266
  • Poulsen B. J., Young E., Coquilla V., Katz M. Effect of Topical Vehicle Composition on the In Vitro Release of Fluocinolone Acetonide and Its Acetate Ester. J. Pharm. Sci. 1968; 57: 928–933
  • Cooper E. R. Increased Skin Permeability for Lipophilic Molecules. J. Pharm. Sci. 1984; 73: 1153–1156
  • Aungst B. J., Blake J. A., Rogers N. J., Hussain M. A. Transdermal Oxymorphone Formulation Development and Methods for Evaluating Flux and Lag Times for Two Skin Enhancing Vehicles. J. Pharm. Sci. 1990; 79: 1072–1076

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.